Clinical and Epidemiological Features of Melasma in Women of Iran: A Cross-sectional Study

Abstract

Background

Melasma is a chronic skin disorder that is characterized by the accumulation of irregular brown pigments in the skin. Lesions are usually seen on the forehead, temples, upper lip, and cheeks. This disease is one of the most common reasons for women to visit dermatologists.

Aim

The present study was conducted to determine the clinical and epidemiological characteristics of melasma in women referred to the dermatology clinic.

Methods

This is a cross-sectional study that was conducted on 100 women who were referred to the dermatology clinic of Imam Khomeini Hospital in Jiroft City in the first half of 2021 using a convenient sampling method. Data were collected using a researcher-made checklist and analyzed using SPSS-v20 statistical software and descriptive and inferential tests at a significance level of p˂0.05.

Results

The average age of women with melasma was 32.8±0.64 years. The majority of clients had skin type four (57%) and skin type three (30%). The spread of pigmentation was mainly centro facial (62%), and there was a positive family history in 43% of cases. Moreover, it was found that melasma is not related to any of the variables of age, number of children, duration of the disease, marital status, family history, history of hormonal treatment, history of pregnancy and subsequent exacerbation, thyroid disease and polycystic ovary syndrome, and use of night creams and sunscreen.

Conclusion

Melasma is a relatively common disease in Iran. Additional studies are needed to find the epidemiological and underlying variables and treatment of melasma.

Keywords: Melasma, Epidemiology, Skin, Women, Dermatology, Clinical.

1. INTRODUCTION

Facial spots or melasma is a chronic skin disorder that leads to the accumulation of pigments in the skin tissue. This disorder appears as symmetrical, spot-like, and brown spots on the skin. This type of accumulation of pigments on the face is sometimes called chloasma, but because this word means green skin, the term melasma, meaning brown skin, is preferred [1, 2].

Melasma is more common in women than men. Depending on the population studied, only 1 out of 4 or even 1 out of 20 people with melasma are men. In general, this disease starts between the ages of 20 and 40, but it may also start in childhood or before reaching middle age [3, 4].

Melasma is more common in people whose skin is tan or have naturally brown skin (skin types 3 and 4). People who have light skin (skin types 1 and 2) or black people (skin types 5 or 6) are less exposed to melasma [5, 6].

The skin consists of three layers. The outer layer of the epidermis is the middle layer or dermis, and the deepest layer is the hypodermis. The skin is the largest organ of the body and accounts for approximately one-seventh of the body's weight. The skin is responsible for protecting the body. It protects bones, muscles, organs, etc., from cold and against germs, sunlight, moisture, toxins, injuries, and other substances. Moreover, the skin helps regulate the body temperature and prevents the loss of moisture and hydration [7, 8].

The epidermis layer of the skin contains cells called melanocytes that store and produce melanin (pigment). Melanocytes, in response to light, heat, or ultraviolet rays or with any type of hormonal stimulation, produce more melanin or pigment. For this reason, the skin becomes darker or darkens in areas that are called spots [8, 9].

There are three types of melasma based on the depth of pigmentation. Wood's lamp emits black light and is used to determine the depth of skin pigmentation and type of melasma spot. The three types of melasma spots are 1) epidermal (superficial); epidermal melasma has a dark brown color. This type of spot has a clearly defined and clear border and is visible under black light, and in many cases, it is easily treatable. 2) Dermal (intermediate): dermal melasma is light brown or bluish, has a blurred border, is not easily visible under a black light, and does not usually respond well to treatment. 3) Mixed melasma: Mixed or combined melasma, which is the most common type among these three types, has blue and brown spots, shows a mixed pattern under black light, and responds to treatment to some extent [10, 11].

The cause of melasma is complex. The accumulation of pigments in the skin tissue is due to the excessive production of melanin by pigment cells (melanocytes). Melanocytes are absorbed by keratinocytes (epidermal melanosis) or stored in the dermis (dermal melanosis) [12, 13].

The distribution patterns of lesions in different areas of the face are: Centro facial pattern: distribution in the forehead, nose, cheeks, upper lip, and chin; Malar pattern: distribution in the nose and cheeks, and Mandibular pattern: distribution in the ramus of the mandible [14].

Risk factors of melasma can be sunlight, ultraviolet rays, visible or infrared light (heat), hormonal changes in the body, taking drugs, anticonvulsants, contraceptives, estrogen/diethyl acetyl bestrol, genetics, low thyroid curry, pregnancy, soaps and cosmetic products [15, 16].

Studies reported that a genetic background can play a role in developing melasma, as at least one-third of patients report that other family members also have melasma. Melasma is a chronic disorder for many people [17, 18].

Another risk factor associated with melasma may be pregnancy because in the third trimester of pregnancy, more estrogen, progesterone, and melanocyte-stimulating hormones are secreted, and this can cause skin spots during pregnancy. In addition to these studies, it has been shown that postmenopausal women who use progesterone hormone therapy have a significantly increased chance of melasma on their skin [6].

Changes in the level of hormones during pregnancy, hormonal treatment or the use of birth control pills, exposure to sunlight, and some skin products can be the causes of melasma. It is also possible that a genetic component causes this disease because people whose relatives have had skin melasma at least once are more likely to develop melasma spots than others [19, 20].

Since melasma occurs in open areas of the body, especially on the face, it affects the appearance of the sufferers. Although skin lesions rarely affect the physical health of the patient, due to the psychological and social aspects of the disease, it almost always affects the general health of the patient and has an obvious effect on the quality of life of the sufferer, as well as the self-concept and self-confidence of the patient. Despite the importance of melasma and the many problems it causes for women in terms of beauty and cost of treatment, so far, limited studies have been conducted on the clinical and epidemiological characteristics of melasma and its prevalence only in pregnancy. Therefore, in this study, we decided to determine the clinical and epidemiological characteristics of melasma in women referred to the dermatology clinic of Imam Khomeini Hospital in Jiroft City.

2. METHODS AND MATERIALS

This is a cross-sectional (descriptive) study that was conducted using available sampling on 100 women with melasma who were referred to the dermatology clinic of Imam Khomeini Hospital in Jiroft City in the first 6 months of 2021.

One hundred patients referred to the Dermatology Clinic of Imam Khomeini Hospital in Jiroft were evaluated. Female gender, age 15-50 years, absence of concomitant skin disease when referring to inclusion criteria, unwillingness to participate in the study, presence of skin disease or new skin disease were considered as exclusion criteria.

The data collection tool was a checklist made by the researcher. The data was collected by taking the history of the participants and completing a checklist containing demographic information, skin condition, and questions about the previous records of the client. First, women with melasma were identified based on the criteria of the Dermatology Association. After setting the time, a face-to-face meeting was held. In this meeting, the objectives of the research were explained to women with melasma, and those eligible to enter the study were informed about the conditions and details of the study by the attending physician. If they wanted to participate in this research, a written consent form was obtained from them, then the necessary questions were asked from the applicants based on the checklist, and the necessary examinations were performed on them.

To check the validity of the content, the checklist was given to 6 faculty members related to the topic of the research, and they were asked about the relevance of each item from the checklist to a four-choice question, including 1) irrelevant, 2) relevant but needs serious revision, 3) is relevant but needs partial revision, and 4) is completely relevant to answer so that the Content Validity Index (CVI) can be calculated to check the validity of the content and they were also asked to rate each item that should answer a three-choice question, including 1) necessary, 2) useful but unnecessary, and 3) unnecessary so that the Content Validity Ratio (CVR) index can be calculated. Considering that the CVI score was 0.86 and the CVR score was 0.58, the content validity of the checklist was confirmed. Cronbach's alpha was used to measure reliability, which was 0.85.

To consider ethical considerations, data was collected after obtaining the code of ethics and making the necessary arrangements. The data were collected without the names and characteristics of the patients, and all the information of the patients, including the name and national information, remained confidential both during the study and after the study was completed, and the results were reported in general. SPSS version 22 software was used for data analysis. The Kolmogorov-Smirnov test was used to test whether the data followed a normal distribution, and the Quantitative data were expressed as Mean and Standard deviation. An Independent t-test was used to compare the involvement profiles between skin type groups. ANCOVA test was used to check the confounding effects. A significance level of less than 0.05 was considered.

3. RESULTS

In this study, 100 women with melasma were referred to the dermatology clinic of Imam Khomeini Hospital, affiliated with Jiroft University of Medical Sciences, during the first six months of 2019.

The average age of the studied women was 32.8 ± 0.64 years, and 84% were married. The average number of children was 1.53±0.12, and the average duration of melasma was 4.63±0.38 years (Table 1).

Table 2 presents the distribution of the statistical population according to skin type, family history, history of baking bread, history of long exposure to the sun, history of pregnancy in terms of exacerbation or occurrence of symptoms after pregnancy, history of hormonal treatment, history of thyroid disease, history of syndrome polycystic ovary, use of night cream, use of sunscreen, and melasma distribution pattern on the face (Table 2).

Table 1.
Distribution of the statistical population according to demographic variables.
Total Number of People 100
Age [years] [mean ± standard deviation] 32.8±0.64
Number of children [number] [mean ± standard deviation] 1.53±0.12
Duration of infection [years] [mean ± standard deviation] 4.63±0.38
Marriage [married] [number] [percentage] 84 (84 percent)
Table 2.
Distribution of statistical population according to skin type.
Variables Frequency Percent
Skin type 2 2 2.0
3 30 30.0
4 57 57.0
5 11 11.0
Sum 100 100.0
Historical family Yes 43 43.0
No 57 57.0
Total 100 100.0
History of baking bread Yes 20 20.0
No 80 80.0
Total 100 100.0
Sun exposure history Yes 40 40.0
No 60 60.0
Total 100 100.0
History of exacerbation or occurrence of symptoms after pregnancy Yes 43 43.0
No 57 57.0
Total 100 100.0
History of hormone therapy Yes 43 43.0
No 57 57.0
Total 100 100.0
History of thyroid disease Yes 11 11.0
No 89 89.0
Total 100 100.0
History of polycystic ovary syndrome Yes 22 22.0
No 78 78.0
Total 100 100.0
Use night cream Yes 39 39.0
No 61 61.0
Total 100 100.0
Use of sunscreen Yes 36 36.0
No 64 64.0
Total 100 100.0
Dispersion pattern of melasma on the face Malar 34 34.0
Centrofacial 62 62.0
Mandibular 4 4.0
Total 100 100.0
Table 3.
Distribution of melasma on the face according to marital status, skin type, family history, history of baking bread, history of long exposure to the sun, occurrence or exacerbation of symptoms after pregnancy, and use of hormonal drugs.
Variables Marital Status Sum
Single Married
Conflict pattern Malar Number 6 28 34
Percentage in disease pattern 17.6% 82.4% 100.0%
Centrofacial Number 9 53 62
Percentage in disease pattern 14.5% 85.5% 100.0%
mandibular Number 1 3 4
Percentage in disease pattern 25.0% 75.0% 100.0%
Sum Number 16 84 100
Percentage in disease pattern 16.0% 84.0% 100.0%
Variables Skin Type Sum
- 2 3 4 5
Conflict pattern Malar Number 2 10 16 6 34
Percentage in disease pattern 5.9% 29.4% 47.1% 17.6% 100.0%
Centrofacial Number 0 20 38 4 62
Percentage in disease pattern 0.0% 32.3% 61.3% 6.5% 100.0%
Mandibular Number 0 0 3 1 4
Percentage in disease pattern 0.0% 0.0% 75.0% 25.0% 100.0%
Sum Number Number 30 57 11 100
Percentage in disease pattern Percentage in disease pattern 30.0% 57.0% 11.0% 100.0%
Variables Family History Sum
Yes No
Conflict pattern Malar Number 13 21 34
Percentage in disease pattern 38.2% 61.8% 100.0%
Centrofacial Number 28 34 62
Percentage in disease pattern 45.2% 54.8% 100.0%
Mandibular Number 2 2 4
Percentage in disease pattern 50.0% 50.0% 100.0%
Sum Number 43 57 100
Percentage in disease pattern 43.0% 57.0% 100.0%
Variables History of Baking Bread Sum
Yes No
Conflict pattern Malar Number 7 27 34
Percentage in disease pattern 20.6% 79.4% 100.0%
Centrofacial Number 13 49 62
Percentage in disease pattern 21.0% 79.0% 100.0%
Mandibular Number 0 4 4
Percentage in disease pattern 0.0% 100.0% 100.0%
Sum Number 20 80 100
Percentage in disease pattern 20.0% 80.0% 100.0%
Variables History of Long Exposure to the Sun Sum
Yes No
Conflict pattern Malar Number 15 19 34
Percentage in disease pattern 44.1% 55.9% 100.0%
Centrofacial Number 24 38 62
Percentage in disease pattern 38.7% 61.3% 100.0%
Mandibular Number 1 3 4
Percentage in disease pattern 25.0% 75.0% 100.0%
Sum Number Number 60 100
Percentage in disease pattern Percentage in disease pattern 60.0% 100.0%
Variables Occurrence or Exacerbation of Symptoms after Pregnancy Sum
Yes No
Conflict pattern Malar Number 17 17 34
Percentage in disease pattern 50.0% 50.0% 100.0%
Centrofacial Number 26 36 62
Percentage in disease pattern 41.9% 58.1% 100.0%
Mandibular Number 0 4 4
Percentage in disease pattern 0.0% 100.0% 100.0%
Sum Number Number 57 100
Percentage in disease pattern Percentage in disease pattern 57.0% 100.0%

Regarding age, the sum of squares between groups was 103.67, the sum of squares within the group was 3916.33, and the total sum of squares was 0.4020. The F value for age was equal to 1.28, and it was not statistically significant (P-value=0.35). In other words, the hypothesis was not accepted and age has no effect on the different groups of the conflict pattern.

Regarding the number of children, the sum of squares between groups was 5.27, the sum of squares within groups was 129.64, and the total sum of squares was 134.91. The F value for the number of children was equal to 1.97, and it was not statistically significant at the P<0.05 level. In other words, the hypothesis was not accepted. The number of children did not affect the different groups of the conflict pattern.

Regarding the years of disease, the sum of squares between groups was 55.67, the sum of squares within groups was 1353.64, and the sum of squares was 1409.31. The F value for the years of infection was equal to 1.99 and was not statistically significant (P-value=0.38). In other words, the hypothesis was not accepted. The years of infection did not affect the different groups of the conflict pattern.

The relationship between marriage and melasma of the patients was investigated using a cross table. According to the chi-square test, there was no statistically significant relationship between marriage, skin type, family history, history of baking bread, history of long-term exposure to the sun, occurrence or exacerbation of symptoms after pregnancy, and the use of hormonal drugs and melasma in patients ((P-value=0.25)) (Table 3).

The relationship between the history of thyroid disease and melasma was investigated using a cross table. According to the chi-square test, there was no statistically significant relationship between the history of polycystic ovary syndrome, history of thyroid disease, and history of using night cream, sunscreen, and melasma (P-value=0.31) (Table 4).

4. DISCUSSION

Melasma is an acquired hypomelanosis that occurs in the form of irregular light to dark-brown macules and patches in sun-exposed areas of the body. Lesions are usually seen on the forehead, temples, upper lip, and cheeks [21].

The findings of the present study showed that the women with melasma had no history of specific underlying disease or skin disease, and the majority were in their fourth decade of life. This research finding is in line with the study by Sarkar et al. [22], but it was significantly different from the study by Handa et al. [23]. This difference in the findings could be due to the selection of age groups, gender, and different geographical conditions.

Table 4.
Distribution of melasma according to history of polycystic ovary syndrome, history of thyroid disease, and history of using night cream and sunscreen.
Variables History of Polycystic Ovary Syndrome Sum
Yes No
Conflict pattern Malar Number 7 27 34
Percentage in disease pattern 20.6% 79.4% 100.0%
Centrofacial Number 15 47 62
Percentage in disease pattern 24.2% 75.8% 100.0%
Mandibular Number 0 4 4
Percentage in disease pattern 0.0% 100.0% 100.0%
Sum Number 22 78 100
Percentage in disease pattern 22.0% 78.0% 100.0%
Variables History of Thyroid Disease Sum
Yes No
Conflict pattern Malar Number 2 32 34
Percentage in disease pattern 5.9% 94.1% 100.0%
Centrofacial Number 9 53 62
Percentage in disease pattern 14.5% 85.5% 100.0%
Mandibular Number 0 4 4
Percentage in disease pattern 0.0% 100.0% 100.0%
Sum Number 11 89 100
Percentage in disease pattern 11.0% 89.0% 100.0%
Variables History of using a Night Cream Sum
Yes No
Conflict patterns Malar Number 9 25 34
Percentage in disease pattern 26.5% 73.5% 100.0%
Centrofacial Number 28 34 62
Percentage in disease pattern 45.2% 54.8% 100.0%
Mandibular Number 2 2 4
Percentage in disease pattern 50.0% 50.0% 100.0%
Sum Number 39 61 100
Percentage in disease pattern 39.0% 61.0% 100.0%
Variables History of using sunscreen Sum
Yes No
Conflict pattern Malar Number 10 24 34
Percentage in disease pattern 29.4% 70.6% 100.0%
Centrofacial Number 23 39 62
Percentage in disease pattern 37.1% 62.9% 100.0%
Mandibular Number 3 1 4
Percentage in disease pattern 75.0% 25.0% 100.0%
Sum Number 36 64 100
Percentage in disease pattern 36.0% 64.0% 100.0%

The findings of the present study showed that the majority of clients had skin type three and four. This type of melasma is common among Iranians. In a study by Sarkar et al., most of the studied cases had medium skin type [22]. Moreover, the issue of ethnicity and race living in the study area should also be taken into account, which can be a confounding factor in the results of the study, especially in terms of skin type.

The findings of the present study showed that the majority of patients did not have long exposure to the sun, which was in line with the results of a study by Handa et al. [23].

The findings of the present study showed that among the studied patients, family history did not affect the disease. This finding was contradictory to the findings of studies by Lee et al. [24] and Adalatkhah et al. [25]. This difference in findings could be due to ethnic and racial differences in different research environments.

The findings of the present study showed that most of the affected people had no history of baking bread, which was contrary to the study by Sarkar et al. [22]. The results of their study showed that the duration of exposure to fire and cooking, as well as exposure to occupational heat, may be related to the severity of melasma. This difference in research findings can be related to the selection of different study groups in terms of age, sex, occupation, and different geographical conditions.

The findings of the present study showed that the majority of clients did not have a positive history of long-term exposure to the sun. This finding was in agreement with the study by Handa et al. [23] and contrary to the study by Lee et al. [24] and Sarkar et al. [22]. This difference could be due to the selection of different groups in terms of age, gender, occupation, and geographical conditions.

The findings of the present study regarding the occurrence or exacerbation of symptoms after pregnancy showed that among the studied patients, the history of pregnancy did not affect the occurrence or exacerbation of disease symptoms. This issue is largely contradictory to the existing studies and knowledge regarding the exacerbation of disease symptoms during and after pregnancy. The results of studies show that melasma has a significant relationship with pregnancy, and pregnancy is known as one of the underlying factors of melasma [5, 24, 26].

The findings of the present study showed that the history of taking hormonal drugs was not related to the occurrence or exacerbation of disease symptoms, and this finding was in line with the findings of a study by Farnaghi et al. [27]. This finding of the present study was inconsistent with the results of a study by Athar et al. [5], demonstrating that the use of hormonal drugs and contraceptives has a significant relationship with melasma.

The findings of the present study showed that the majority of clients (melasma sufferers) had no history of thyroid problems and polycystic ovary syndrome. This finding of the present study was in line with the results of a study by Athar et al., which reported no significant relationship between suffering from melasma and thyroid problems in the studied subjects [5].

The findings of the present study showed that about two-thirds of the affected patients did not use night cream or sunscreen. This finding agreed with the study by Sarkar et al. [22]. Moreover, in this regard, the results of a study by Athar et al. reported no significant relationship between melasma and the use of sunscreen.

he findings of the present study were examined in terms of the conflict pattern. The melasma in the majority of clients was centrofacial. This finding of the current research was in line with two studies that were conducted in our country by Farnaghi et al. [27] and Adalatkhah et al. This finding of the current study was inconsistent with the results of the study by Handa et al. [23], in which the predominant pattern of conflict in the studied subjects was malar.

CONCLUSION AND RECOMMENDATIONS

he results of the present study showed that melasma is not related to any of the variables of age, number of children, duration of the disease, marital status, family history, history of hormonal treatment, history of pregnancy and subsequent exacerbation, thyroid disease and polycystic ovary syndrome, and use of creams. No significant relationship was found between nighttime and sunscreen. Therefore, considering that melasma is a relatively common disease in Iran, it is necessary to conduct complementary and systematic studies to find its epidemiological and underlying variables and treatment.

LIMITATIONS OF THE STUDY

This study had limitations. Among the several limitations of the current research, the following can be mentioned:

1- This research was limited to comparing the results with other related studies. This limitation has been due to the lack of resources and related studies.

2- This research is cross-sectional in nature. This makes it difficult to draw conclusions about causality. It is suggested that researchers design and implement future studies related to case-control type.

3- The results of the present study can be generalized to women referring to the skin clinic of Imam Khomeini Hospital in Jiroft. Therefore, the generalization of the findings of the present study is limited and caution should be taken in generalizing the results.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

This study reports the results of a research project approved by the Jiroft University of Medical Sciences with the code of ethics (IR.JMU.REC.1400.063).

HUMAN AND ANIMAL RIGHTS

All procedures performed in the study involving human participants were according to the ethical standards of the institutional and national research committee and with the 1975 Helsinki Declaration and its later amendments or comparable ethical standards.

CONSENT FOR PUBLICATION

Written informed consent has been taken from the patients.

STANDARDS OF REPORTING

STROBE guidelines were followed.

AVAILABILITY OF DATA AND MATERIALS

The data and supportive information are available within the article.

FUNDING

This research was done with the financial support of Jiroft University of Medical Sciences.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

The authors would like to express their gratitude to the respected mentors and advisors, the respected research vice president of Jiroft University of Medical Sciences and Health Services, the participants in the study, the officials of Imam Khomeini (RA) Jiroft Hospital, and all the people who helped us in conducting this study.

REFERENCES

1
Arora P, Sarkar R, Garg V, Sonthalia S, Gokhale N. Melasma update. Indian Dermatol Online J 2014; 5(4): 426-35.
2
Sheth VM, Pandya AG. Melasma: A comprehensive update. J Am Acad Dermatol 2011; 65(4): 699-714.
3
Vázquez M, Maldonado H, Benmamán C, Sánchez JL. Melasma in men. Int J Dermatol 1988; 27(1): 25-7.
4
Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. J Am Acad Dermatol 2006; 54(5)(Suppl. 2): S272-81.
5
Moin A, Jabery Z, Fallah N. Prevalence and awareness of melasma during pregnancy. Int J Dermatol 2006; 45(3): 285-8.
6
Victor FC, Gelber J, Rao B. Melasma: A review. J Cutan Med Surg 2004; 8(2): 97-102.
7
Chuong C-M, Nickoloff BJ, Elias PM, et al. What is the ‘true’ function of skin? Exp Dermatol 2002; 11(2): 159-87.
8
Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: Holistic approach to its origin and functions. Br J Dermatol 2008; 159(1): 23-34.
9
Cichorek M, Wachulska M, Stasiewicz A, Tymińska A. Skin melanocytes: Biology and development. Postepy Dermatol Alergol 2013; 30(1): 30-46.
10
Shankar K, Godse K, Aurangabadkar S, et al. Evidence-based treatment for melasma: Expert opinion and a review. Dermatol Ther 2014; 4(2): 165-86.
11
Prignano F, Ortonne JP, Buggiani G, Lotti T. Therapeutical approaches in melasma. Dermatol Clin 2007; 25(3): 337-342, viii.
12
Rajanala S, Maymone MBCC, Vashi NA. Melasma pathogenesis: A review of the latest research, pathological findings, and investigational therapies. Dermatol Online J 2019; 25(10): 25.
13
Miot LD, Miot HA, Polettini J, Silva MG, Marques ME. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: A comparative study. Am J Dermatopathol 2010; 32(7): 676-82.
14
Vitalevich MA, Iskanderovna AM, Akramovna YS, Komilovna IF. Diagnostic and treatment management for skin hyperpigmentation. Eur Sci Rev 2018; 107-11.
15
Rathi SK, Achar A. Melasma: A clinico-epidemiological study of 312 cases. Indian J Dermatol 2011; 56(4): 380-2.
16
Handel AC, Miot LDB, Miot HA. Melasma: A clinical and epidemiological review. An Bras Dermatol 2014; 89(5): 771-82.
17
Rathore S, Gupta S, Gupta V. Pattern and prevalence of physiological cutaneous changes in pregnancy: A study of 2000 antenatal women. Indian J Dermatol Venereol Leprol 2011; 77(3): 402.
18
Tyler KH. Physiological skin changes during pregnancy. Clin Obstet Gynecol 2015; 58(1): 119-24.
19
Motosko CC, Bieber AK, Pomeranz MK, Stein JA, Martires KJ. Physiologic changes of pregnancy: A review of the literature. Int J Womens Dermatol 2017; 3(4): 219-24.
20
Pichardo R, Vallejos Q, Feldman SR, et al. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol 2009; 48(1): 22-6.
21
Passeron T. Melasma pathogenesis and influencing factors – An overview of the latest research. J Eur Acad Dermatol Venereol 2013; 27(s1)(Suppl. 1): 5-6.
22
Sarkar R, Jagadeesan S, Basavapura Madegowda S, et al. Clinical and epidemiologic features of melasma: A multicentric cross‐sectional study from India. Int J Dermatol 2019; 58(11): 1305-10.
23
Handa S, De D, Khullar G, Radotra BD, Sachdeva N. The clinicoaetiological, hormonal and histopathological characteristics of melasma in men. Clin Exp Dermatol 2018; 43(1): 36-41.
24
Lee AY. An updated review of melasma pathogenesis. Zhonghua Pifuke Yixue Zazhi 2014; 32(4): 233-9.
25
Edalat Khah H, Amani F, Rezaifar G. Prevalence of melasma in women in ardebil city in 2002. Indian J Dermatol 2004; 7(2): 72-7.
26
Guinot C, Cheffai S, Latreille J, et al. Aggravating factors for melasma: A prospective study in 197 Tunisian patients. J Eur Acad Dermatol Venereol 2010; 24(9): 1060-9.
27
Farnaghi F, Seyrafi H. The study of clinical & lab findings of 65 Melasma patients who admitted to razi hospital. J Intern Med 2000; 6(1): 44-8.